Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
oligosaccharide/diarrea
Il collegamento viene salvato negli appunti
Pagina 1 a partire dal 19 risultati
Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
Solo gli utenti registrati possono tradurre articoli
Entra registrati
This application claims the benefit of U.S. Provisional Application No. 60/001,036, filed Jul. 11, 1995.
FIELD OF THE INVENTION
The present invention relates to a method of reducing duration of diarrhea by enterally administering to humans indigestible oligosaccharides.
BACKGROUND OF THE
Methods for the treatment and prevention of diarrhea
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention relates to a method for the treatment and prevention of diarrhea comprising administering to humans a sugar selected from the group consisting of a caramel composition comprising a high content of fructose oligosaccharides, termed sucrose thermal
Oral rehydration solution containing indigestible oligosaccharides
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to an oral rehydration solution containing indigestible oligosaccharides for the inhibition of disease states associated with Clostridium difficile.
BACKGROUND OF INVENTION
The successful management of acute diarrhea is still a challenge today. Acute
Inhibition of C. difficile infections by indigestible oligosaccharides
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to the use of indigestible oligosaccharides in the inhibition of disease states by Clostridium difficile.
BACKGROUND OF INVENTION
Clostridium difficile (C. difficile) is the leading known cause of nosocomial infections. Greenough et al., "Diarrhea in the
Treatment of traveller's diarrhea
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to treatment of traveller's diarrhea, including diarrhea caused by enterotoxigenic Escherichia coli (ETEC). More specifically, the invention concerns neutralization and removal of E. coli heat-labile toxin (LT) associated with ETEC. This invention also
Treatment of traveller's diarrhea
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to treatment of traveller's diarrhea, including diarrhea caused by enterotoxigenic Escherichia coli (ETEC). More specifically, the invention concerns neutralization and removal of E. coli heat-labile toxin (LT) associated with ETEC. This invention also
Treatment of traveller's diarrhea
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to treatment of traveller's diarrhea, including diarrhea caused by enterotoxigenic Escherichia coli (ETEC). More specifically, the invention concerns neutralization and removal of E. coli heat-labile toxin (LT) associated with ETEC. This invention also
Treatment of diarrhea caused by enteropathogenic Escherichia coli
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to treatment of diarrhea, particularly diarrhea caused by enteropathogenic Escherichia coli (EPEC). More specifically, the invention concerns compositions and methods which may be used to prevent EPEC infection or ameliorate symptoms caused by EPEC
Treatment of antibiotic associated diarrhea
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC). More specifically, the invention concerns neutralization of C. difficile toxin A associated with
Treatment of traveller's diarrhea
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to treatment of traveller's diarrhea, including diarrhea caused by enterotoxigenic Escherichia coli (ETEC). More specifically, the invention concerns neutralization and removal of E. coli heat-labile toxin (LT) associated with ETEC. This invention also
Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates to the treatment of diarrhea and related conditions caused by pathogenic E. coli infection. More specifically, this invention is drawn to the unexpected discovery that by administering a composition which binds and removes the
Lactobacillus bifidus growth promoting composition and use thereof
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention pertains to a composition that can be orally administered to bring intestinal flora to a good state and efficiently control intestinal function, and the use thereof. In further detail, the present invention pertains to a Lactobacillus bifidus growth promoting
Prebiotic compositions
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention concerns prebiotic compositions comprising of soluble fibres, in particular fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS), and their use in the treatment or prevention of gastrointestinal tract disorders, such as inflammatory bowel disease (IBD), diarrhoea
Prebiotic compositions
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention concerns prebiotic compositions comprising of soluble fibres, in particular fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS), and their use in the treatment or prevention of gastrointestinal tract disorders, such as inflammatory bowel disease (IBD), diarrhoea
Method of binding and removing toxin A
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC). More specifically, the invention concerns neutralization of C. difficile toxin A associated with
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
